NCT00039975View on ClinicalTrials.gov

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2004

Conditions
HIV InfectionsCardiovascular DiseasesHypertension
Interventions
DRUG

Indinavir sulfate

DRUG

Ritonavir

DRUG

Amlodipine

DRUG

Diltiazem HCl

Trial Locations (9)

10021

Cornell Univ Med Ctr, New York

14642

Univ of Rochester Medical Center, Rochester

21287

Johns Hopkins Hosp, Baltimore

55455

Univ of Minnesota, Minneapolis

63108

Washington Univ (St. Louis), St Louis

80262

Univ of Colorado Health Sciences Ctr, Denver

94110

Univ of California San Francisco, San Francisco

452670405

Univ of Cincinnati, Cincinnati

943055107

Stanford Univ Med Ctr, Stanford

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00039975 - Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers | Biotech Hunter | Biotech Hunter